发明名称 |
Vaccines directed to langerhans cells |
摘要 |
The present invention includes isolated anti-Langerin vaccines, methods for making and using an isolated anti-Langerin antibody or binding fragment thereof and one or more antigenic peptides at the carboxy-terminus of the isolated anti-Langerin antibody, wherein when two or more antigenic peptides are present, the peptides are separated by the one or more linker peptides that comprise at least one glycosylation site. The present invention also includes isolated vectors for the expression of the anti-Langerin antigen delivery vectors and their manufactures and use. |
申请公布号 |
US9315580(B2) |
申请公布日期 |
2016.04.19 |
申请号 |
US201313863131 |
申请日期 |
2013.04.15 |
申请人 |
Baylor Research Institute |
发明人 |
Banchereau Jacques F.;Zurawski Gerard;Zurawski Sandra;Klechevsky Eynav;Oh SangKon |
分类号 |
C07K16/00;C12P21/08;C07K16/28;A61K39/00;A61K39/145;A61K39/21;C07K14/47;C12N7/00;C07K14/005;A61K39/12 |
主分类号 |
C07K16/00 |
代理机构 |
Norton Rose Fulbright US LLP |
代理人 |
Norton Rose Fulbright US LLP |
主权项 |
1. An isolated Langerin binding antibody or antigen binding fragment thereof comprising:
i) an antibody light chain variable domain comprising light chain complementarity regions CDR1L, CDR2L and CDR3L from SEQ ID NO: 2 and an antibody heavy chain variable domain comprising heavy chain complementarity regions CDR1H, CDR2H and CDR3H from SEQ ID NO: 4 or, ii) an antibody light chain variable domain comprising light chain complementarity regions CDR1L, CDR2L and CDR3L from SEQ ID NO: 6 and an antibody heavy chain variable domain comprising heavy chain complementarity regions CDR1H, CDR2H and CDR3H from SEQ ID NO: 8. |
地址 |
Dallas TX US |